Nucleobase adducts bind MR1 and stimulate MR1-restricted T cells.

Autor: Vacchini A; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Chancellor A; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Yang Q; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Colombo R; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Spagnuolo J; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Berloffa G; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Joss D; Department of Chemistry, University of Basel, Basel 4056, Switzerland., Øyås O; Department of Biosystems Science and Engineering and SIB Swiss Institute of Bioinformatics, ETH Zurich, Basel 4058, Switzerland., Lecchi C; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA., De Simone G; Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano 20156, Italy., Beshirova A; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Nosi V; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Loureiro JP; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Morabito A; Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano 20156, Italy., De Gregorio C; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Pfeffer M; Department of Chemistry, University of Basel, Basel 4056, Switzerland., Schaefer V; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Prota G; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Zippelius A; Cancer Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Stelling J; Department of Biosystems Science and Engineering and SIB Swiss Institute of Bioinformatics, ETH Zurich, Basel 4058, Switzerland., Häussinger D; Department of Chemistry, University of Basel, Basel 4056, Switzerland., Brunelli L; Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano 20156, Italy., Villalta P; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.; Department of Medicinal Chemistry, University of Minnesota, Minneapolis, MN 55455, USA., Lepore M; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Davoli E; Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano 20156, Italy., Balbo S; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA., Mori L; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., De Libero G; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland.

Publikováno v: Science immunology [Sci Immunol] 2024 May 10; Vol. 9 (95), pp. eadn0126. Date of Electronic Publication: 2024 May 10.

Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods.

Autor: Otte F; Molecular Virology, Department Biomedicine, University of Basel, 4009 Basel, Switzerland., Zhang Y; Molecular Virology, Department Biomedicine, University of Basel, 4009 Basel, Switzerland., Spagnuolo J; Experimental Immunology, Department Biomedicine, University of Basel, 4056 Basel, Switzerland., Thielen A; Seq-IT GmbH & Co.KG, 67655 Kaiserslautern, Germany., Däumer M; Seq-IT GmbH & Co.KG, 67655 Kaiserslautern, Germany., Wiethe C; Biolegend GmbH, 56070 Koblenz, Germany., Stoeckle M; Infectiology, University Hospital Basel, 4031 Basel, Switzerland., Kusejko K; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, and Institute of Medical Virology, University of Zurich, 8091 Zurich, Switzerland., Klein F; Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany., Metzner KJ; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, and Institute of Medical Virology, University of Zurich, 8091 Zurich, Switzerland., Klimkait T; Molecular Virology, Department Biomedicine, University of Basel, 4009 Basel, Switzerland.

Publikováno v: Cell reports methods [Cell Rep Methods] 2023 May 23; Vol. 3 (6), pp. 100485. Date of Electronic Publication: 2023 May 23 (Print Publication: 2023).

Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer.

Autor: Lara Moscoloni LF; Hospital Complejo Medico Churruca - Visca, Buenos Aires, Argentina., Santarelli M; Hospital Complejo Medico Churruca - Visca, Buenos Aires, Argentina., Spagnuolo J; Hospital Complejo Medico Churruca - Visca, Buenos Aires, Argentina.

Publikováno v: Urology case reports [Urol Case Rep] 2021 Mar 04; Vol. 37, pp. 101629. Date of Electronic Publication: 2021 Mar 04 (Print Publication: 2021).

Characterization of Tumor-Infiltrating Lymphocyte-Derived Atypical TCRs Recognizing Breast Cancer in an MR1-Dependent Manner.

Autor: Hayee, Abdul¹ (AUTHOR) drahayee@med.u-toyama.ac.jp, Kobayashi, Eiji^1,2 (AUTHOR) ekoba@med.u-toyama.ac.jp, Motozono, Chihiro³ (AUTHOR) motozono@kumamoto-u.ac.jp, Hamana, Hiroshi^1,4 (AUTHOR) drvietmy159@gmail.com, My, Ha Thi Viet¹ (AUTHOR) satyamag@med.u-toyama.ac.jp, Okada, Takuya⁵ (AUTHOR) tokada@eng.u-toyama.ac.jp, Toyooka, Naoki⁵ (AUTHOR) toyooka@eng.u-toyama.ac.jp, Yamaguchi, Satoshi^1,6 (AUTHOR) toza@eng.u-toyama.ac.jp, Ozawa, Tatsuhiko^1,2 (AUTHOR), Kishi, Hiroyuki^1,2 (AUTHOR) ekoba@med.u-toyama.ac.jp

Publikováno v: Cells (2073-4409). Oct2024, Vol. 13 Issue 20, p1711. 16p.

Interferon lambda 4 can directly activate human CD19 ⁺ B cells and CD8 ⁺ T cells.

Autor: Coto-Llerena M; Department of Biomedicine, Hepatology, University Hospital and University of Basel, Basel, Switzerland., Lepore M; Department of Biomedicine, Experimental Immunology, University Hospital and University of Basel, Basel, Switzerland., Spagnuolo J; Department of Biomedicine, Experimental Immunology, University Hospital and University of Basel, Basel, Switzerland., Di Blasi D; Department of Biomedicine, Hepatology, University Hospital and University of Basel, Basel, Switzerland.; Department of Biomedicine, Experimental Immunology, University Hospital and University of Basel, Basel, Switzerland., Calabrese D; Department of Biomedicine, Hepatology, University Hospital and University of Basel, Basel, Switzerland., Suslov A; Department of Biomedicine, Hepatology, University Hospital and University of Basel, Basel, Switzerland., Bantug G; Department of Biomedicine, Immunobiology, University Hospital and University of Basel, Basel, Switzerland., Duong FH; Department of Biomedicine, Hepatology, University Hospital and University of Basel, Basel, Switzerland., Terracciano LM; Molecular Pathology Division, Institute of Pathology, University Hospital Basel, Basel, Switzerland., De Libero G; Department of Biomedicine, Experimental Immunology, University Hospital and University of Basel, Basel, Switzerland gennaro.delibero@unibas.ch., Heim MH; Department of Biomedicine, Hepatology, University Hospital and University of Basel, Basel, Switzerland markus.heim@unibas.ch.; Division of Gastroenterology and Hepatology, Clarunis, University Center for Gastrointestinal and Liver Diseases, Basel, Switzerland.

Publikováno v: Life science alliance [Life Sci Alliance] 2020 Nov 06; Vol. 4 (1). Date of Electronic Publication: 2020 Nov 06 (Print Publication: 2021).